Related Articles
Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer
Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder
MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer
Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer